AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $13,858,000 | -28.5% | 677,663 | -47.6% | 1.96% | -1.9% |
| Q3 2016 | $19,394,000 | +38.6% | 1,292,940 | 0.0% | 2.00% | +3.3% |
| Q2 2016 | $13,990,000 | -20.2% | 1,292,940 | 0.0% | 1.94% | -13.6% |
| Q1 2016 | $17,532,000 | +20.3% | 1,292,940 | +63.6% | 2.24% | +55.3% |
| Q4 2015 | $14,579,000 | -27.1% | 790,200 | 0.0% | 1.44% | -49.8% |
| Q3 2015 | $20,008,000 | – | 790,200 | – | 2.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,100,146 | $117,248,000 | 40.96% |
| TLP GROUP LLC | 1,050,000 | $39,711,000 | 27.53% |
| Aisling Capital LLC | 2,240,000 | $84,717,000 | 16.74% |
| Foresite Capital Management III, LLC | 764,824 | $28,926,000 | 8.12% |
| AlpInvest Partners B.V. | 51,498 | $1,948,000 | 6.95% |
| Vivo Capital, LLC | 643,626 | $24,342,000 | 5.21% |
| GREAT POINT PARTNERS LLC | 573,550 | $21,692,000 | 3.70% |
| Eventide Asset Management | 1,226,000 | $46,367,000 | 2.42% |
| Palo Alto Investors LP | 1,146,419 | $43,358,000 | 1.87% |
| HAMILTON LANE ADVISORS LLC | 78,846 | $2,982,000 | 1.54% |